MEDTRONIC PLC

(MDT)
  Report
Delayed Nyse  -  05/20 04:00:01 pm EDT
102.53 USD   -0.21%
05/19Medtronic to announce financial results for its fourth quarter and full fiscal year 2022
PR
05/19Oppenheimer Adjusts Medtronic Price Target to $120 From $125, Maintains Outperform Rating
MT
05/19Opsens Presents Results of First-in-human Study of SavvyWire at European Conf
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Medtronic Says Data From DTM Spinal Cord Stimulation Endurance Therapy Study Shows Meaningful Pain Relief

01/14/2022 | 12:54pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
MEDTRONIC PLC -0.21% 102.53 Delayed Quote.-0.89%
ON SEMICONDUCTOR CORPORATION 0.70% 56.46 Delayed Quote.-16.87%
SCS GROUP PLC 2.99% 172.5 Delayed Quote.-26.54%
All news about MEDTRONIC PLC
05/19Medtronic to announce financial results for its fourth quarter and full fiscal year 202..
PR
05/19Oppenheimer Adjusts Medtronic Price Target to $120 From $125, Maintains Outperform Rati..
MT
05/19Opsens Presents Results of First-in-human Study of SavvyWire at European Conf
MT
05/17Citigroup Adjusts Medtronic's Price Target to $120 From $127, Reiterates Buy Rating
MT
05/17EUROPCR : Medtronic renal denervation system shows better blood pressure control with sign..
AQ
05/13Medtronic Says FDA Approves Onyx Frontier Drug-Eluting Stent
DJ
05/13Medtronic Receives US FDA Ok for Onyx Frontier Drug-Eluting Coronary Stent System
MT
05/13Medtronic receives FDA approval for latest generation drug-eluting coronary stent syste..
PR
05/13Medtronic Receives FDA Approval for Latest Generation Drug-Eluting Coronary Stent Syste..
CI
05/13Medtronic Completes Purchase Of US Medical Device Group Intersect ENT
MT
More news
Analyst Recommendations on MEDTRONIC PLC
More recommendations
Financials (USD)
Sales 2022 32 071 M - -
Net income 2022 5 743 M - -
Net Debt 2022 20 837 M - -
P/E ratio 2022 25,8x
Yield 2022 2,38%
Capitalization 138 B 138 B -
EV / Sales 2022 4,94x
EV / Sales 2023 4,70x
Nbr of Employees 90 000
Free-Float 99,8%
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 102,53 $
Average target price 122,95 $
Spread / Average Target 19,9%
EPS Revisions
Managers and Directors
Geoffrey Straub Martha Chairman & Chief Executive Officer
Megan Fulton Riddle Vice President
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Laura Mauri Chief Scientific, Medical & Regulatory Officer
Gregory L. Smith Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
MEDTRONIC PLC-0.89%137 548
ABBOTT LABORATORIES-19.54%198 277
BECTON, DICKINSON AND COMPANY2.66%71 922
HOYA CORPORATION-22.41%37 902
BAXTER INTERNATIONAL INC.-14.69%36 873
DEXCOM, INC.-40.18%31 521